Enlivex (FRA:1BT) OCF Margin %: 0.00% (As of Dec. 2025)


FRA:1BT Enlivex Ltd FRA:1BT
31 GF Score
Price €0.53
! 2 Warning Signs
View Full Analysis

What is Enlivex OCF Margin %?

Enlivex FRA:1BT -0.93% 31 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:1BT with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Enlivex ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Enlivex's Cash Flow from Operations for the three months ended in Dec. 2025 was €-2.24 Mil. Enlivex's Revenue for the three months ended in Dec. 2025 was €0.00 Mil. Therefore, Enlivex's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Enlivex's current OCF Yield % is -7.14%.

The historical rank and industry rank for Enlivex's OCF Margin % or its related term are showing as below:


FRA:1BT's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Enlivex OCF Margin % Related Terms

Enlivex OCF Margin % Historical Data

* Premium members only.

The historical data trend for Enlivex's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enlivex OCF Margin % Chart

Enlivex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Enlivex Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:1BT
31GF Score
Enlivex Ltd FRA:1BT
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enlivex OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Enlivex's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-8.895/0
= %

Enlivex's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.243/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Enlivex (FRA:1BT) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Enlivex and its competitors. According to the industry distribution chart, Enlivex ranks #999999 out of 960 companies in the Biotechnology industry.
Is Enlivex's OCF Margin % too high?
Enlivex's current OCF Margin % is 0.00%. Based on the distribution chart, Enlivex ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Enlivex has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Enlivex's OCF Margin % compare to TNXP and UNCY?
According to the Biotechnology industry distribution chart, Enlivex ranks #999999 out of 960 companies for OCF Margin %. This places Enlivex in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Enlivex and its competitors. Enlivex's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enlivex stock overvalued right now?
Enlivex (FRA:1BT) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Enlivex's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Enlivex (FRA:1BT), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enlivex Business Description

Other Exchanges ENLV:USA
Address 14 Einstein Street, Weizmann Science Park, Ness Ziona, ISR, 7403618
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
31GF Score

Get the complete analysis for FRA:1BT

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.53
Price